Global Neurotrophic Keratitis Treatment Market 2018-2022 | Use of rhNGF for Treatment to Boost Demand | Technavio
LONDON--(BUSINESS WIRE)--Oct 12, 2018-- analysts forecast the global neurotrophic keratitis treatment market to grow at a CAGR of over 4% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181011006010/en/
Technavio analysts forecast the global neurotrophic keratitis treatment market to grow at a CAGR of over 4% by 2022. (Graphic: Business Wire)
The use of rhNGF is one of the major trends being witnessed in the . The rhNGF is regarded as a promising therapy for the neurodegeneration of the central and peripheral nervous systems as well as for several other pathological conditions related to the immune system. It is a protein that is naturally produced by the body, and it promotes the development and survival of nerve cells, including those of the retina.
According to Technavio analysts, one of the key factors contributing to the growth of the global neurotrophic keratitis treatment market is the growing geriatric population:
Global neurotrophic keratitis treatment market: Growing geriatric population
The geriatric population has been growing significantly over the last few years globally. Age-related changes in the cornea and ocular surface tissues have a major effect on vision.
According to a senior analyst at Technavio for research on infectious and rare diseases, “Changes in peripheral nerves, including a reduction in the number of specialized peripheral receptors and the deterioration of myelinated and unmyelinated axons, are known to occur with age. Moreover, the number of mucous cells in the conjunctiva may decrease with age. Tear production may also decrease with age, which will make the eyes dry. These changes explain why older people are more likely to develop dry eyes. Thus, the growth of the geriatric population is expected to trigger the growth of neurotrophic keratitis treatment market.”
Global neurotrophic keratitis treatment market: Segmentation analysis
The global neurotrophic keratitis treatment market research report provides market segmentation by product (TA, rhNGF, and others) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
Of the two major products, TA and rhNGF, the TA segment held the largest market share in 2017, contributing to over 42% of the market. This application segment will dominate the global market throughout the forecast period.
The Americas held the largest share of the market in 2017, accounting for close to 40% share, followed by EMEA and APAC respectively. The dominance of the region can be attributed to the rise in the number of product approvals in the US and the increase in funding from various organizations for the development of new drugs for the treatment of neurotrophic keratitis.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181011006010/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 10/12/2018 01:39 AM/DISC: 10/12/2018 01:39 AM